Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline

In this guideline, ASCO convened an expert panel to conduct a systematic review of published phase III randomized controlled trials (2007-2020) on systemic therapy for advanced hepatocellular carcinoma and provide recommended care options for this patient population.

Journal of Clinical Oncology